Shamim Mondal | Alliance University (original) (raw)
Address: Bangalore, India
less
Uploads
Papers by Shamim Mondal
Management Decision
PurposeThis study aims to examine how foreign and domestic firms react to policy uncertainty in a... more PurposeThis study aims to examine how foreign and domestic firms react to policy uncertainty in an emerging economy. In addition, the study investigates if older foreign firms better adapt to policy uncertainty than newer entrants.Design/methodology/approachThe study uses pharmaceutical sales data on India’s cardiovascular segment for January 2011–May 2016. The authors use fixed fixed-effects panel data regression to measure the market reactions of foreign and domestic firms faced with policy uncertainty.FindingsWhile domestic and foreign firms react similarly to anticipated policy changes, foreign firms react more adversely to policy uncertainty. Among foreign firms, early entrants respond less adversely than new entrants.Research limitations/implicationsForeign firms are able to cope with anticipated policy changes in similar vein as the domestic firms by way of a priori reading of the host country’s regulatory landscape. The foreign firms’ response to policy uncertainty is signif...
Vikalpa: The Journal for Decision Makers
Pharmaceutical companies have been spending huge amount of money on marketing and promotions, sal... more Pharmaceutical companies have been spending huge amount of money on marketing and promotions, sales distribution, and travelling done by the sales representatives. However, they find it difficult to directly link the returns with these efforts. This study makes an attempt to examine whether the marketing efforts have significant influence on the sales performance in the industry. It uses the DEA model (Data Envelopment Analysis) to assess the efficiency of marketing efforts by pharmaceutical companies, and uses random effects maximum likelihood panel regression to assess the significance of the impact of marketing efforts.
The Indian pharmaceutical industry is one of the largest in the world both in terms of volume and... more The Indian pharmaceutical industry is one of the largest in the world both in terms of volume and value. Given its critical importance, the sector has been subject to a series of regulatory interventions, which have altered the nature of the industry quite significantly. With enacting the Indian competition Act (2002), India has joined the list of countries that has a robust competition regime. The purpose of this chapter is to understand the pharmaceutical sector through the prism of competition law.
Emerging Markets Review, 2015
We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using r... more We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using rights issues to circumvent regulatory provisions related to creeping acquisitions. We find that promoters use rights issues that do not have specific objectives for purposes of realizing an increase in their shareholdings. We find that a rights issue often follows a year in which the promoter has realized a loss of shareholdings. The results are especially true for firms belonging to a business group.
SSRN Electronic Journal, 2000
ABSTRACT
We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using r... more We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using rights issues to circumvent regulatory provisions related to creeping acquisitions. We find that promoters use rights issues that do not have specific objectives for purposes of realizing an increase in their shareholdings. We find that a rights issue often follows
a year in which the promoter has realized a loss of shareholdings. The results are especially true for firms belonging to a business group.
Management Decision
PurposeThis study aims to examine how foreign and domestic firms react to policy uncertainty in a... more PurposeThis study aims to examine how foreign and domestic firms react to policy uncertainty in an emerging economy. In addition, the study investigates if older foreign firms better adapt to policy uncertainty than newer entrants.Design/methodology/approachThe study uses pharmaceutical sales data on India’s cardiovascular segment for January 2011–May 2016. The authors use fixed fixed-effects panel data regression to measure the market reactions of foreign and domestic firms faced with policy uncertainty.FindingsWhile domestic and foreign firms react similarly to anticipated policy changes, foreign firms react more adversely to policy uncertainty. Among foreign firms, early entrants respond less adversely than new entrants.Research limitations/implicationsForeign firms are able to cope with anticipated policy changes in similar vein as the domestic firms by way of a priori reading of the host country’s regulatory landscape. The foreign firms’ response to policy uncertainty is signif...
Vikalpa: The Journal for Decision Makers
Pharmaceutical companies have been spending huge amount of money on marketing and promotions, sal... more Pharmaceutical companies have been spending huge amount of money on marketing and promotions, sales distribution, and travelling done by the sales representatives. However, they find it difficult to directly link the returns with these efforts. This study makes an attempt to examine whether the marketing efforts have significant influence on the sales performance in the industry. It uses the DEA model (Data Envelopment Analysis) to assess the efficiency of marketing efforts by pharmaceutical companies, and uses random effects maximum likelihood panel regression to assess the significance of the impact of marketing efforts.
The Indian pharmaceutical industry is one of the largest in the world both in terms of volume and... more The Indian pharmaceutical industry is one of the largest in the world both in terms of volume and value. Given its critical importance, the sector has been subject to a series of regulatory interventions, which have altered the nature of the industry quite significantly. With enacting the Indian competition Act (2002), India has joined the list of countries that has a robust competition regime. The purpose of this chapter is to understand the pharmaceutical sector through the prism of competition law.
Emerging Markets Review, 2015
We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using r... more We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using rights issues to circumvent regulatory provisions related to creeping acquisitions. We find that promoters use rights issues that do not have specific objectives for purposes of realizing an increase in their shareholdings. We find that a rights issue often follows a year in which the promoter has realized a loss of shareholdings. The results are especially true for firms belonging to a business group.
SSRN Electronic Journal, 2000
ABSTRACT
We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using r... more We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using rights issues to circumvent regulatory provisions related to creeping acquisitions. We find that promoters use rights issues that do not have specific objectives for purposes of realizing an increase in their shareholdings. We find that a rights issue often follows
a year in which the promoter has realized a loss of shareholdings. The results are especially true for firms belonging to a business group.